Your search returned 3 results.

Results
	1.	A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors. [electronic resource] by Prabhu, Jyothi S Korlimarla, Aruna Desai, Krisha Alexander, Annie Raghavan, Rohini Anupama, Ce Dendukuri, Nandini Manjunath, Suraj Correa, Marjorrie Raman, N Kalamdani, Anjali Prasad, Msn Gopinath, K S Srinath, B S Sridhar, T S Producer: 20140224 In: Journal of Cancer vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells. [electronic resource] by Desai, Krisha Aiyappa, Radhika Prabhu, Jyothi S Nair, Madhumathy G Lawrence, Patrick Varun Korlimarla, Aruna Ce, Anupama Alexander, Annie Kaluve, Rohini S Manjunath, Suraj Correa, Marjorrie Srinath, B S Patil, Shekhar Kalamdani, Anjali Prasad, Msn Sridhar, T S Producer: 20170407 In: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease. [electronic resource] by Prabhu, Jyothi S Korlimarla, Aruna Anupama, C E Alexander, Annie Raghavan, Rohini Kaul, Roma Desai, Krisha Rajarajan, Savitha Manjunath, Suraj Correa, Marjorrie Raman, R Kalamdani, Anjali Prasad, Msn Patil, Shekar Gopinath, K S Srinath, B S Sridhar, T S Publication details: Translational oncology Aug 2017 In: Translational oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)